Aurora Cannabis Expands European Presence with New Websites to Promote Medical Cannabis Leadership

Aurora Cannabis Expands Its European Digital Footprint

In a significant move for its growth strategy, Aurora Cannabis Inc. has unveiled four new websites tailored for key European markets. This initiative highlights the company's commitment to enhancing engagement within the medical cannabis sector. The launch presents Aurora as an industry leader backed by scientific expertise and extensive manufacturing capabilities.

Committed to European Expansion

On February 3, 2026, Aurora Cannabis, listed on NASDAQ under the ticker ACB and also on the TSX, announced its latest effort to strengthen its presence in Europe. The new sites aim to offer localized content that meets the specific needs of healthcare professionals, partners, and prospective employees across various regions. The central European hub, accessible at www.auroramedicine.com, connects users to dedicated platforms for Germany, the UK, and Poland, ensuring relevance and accessibility.

Speaking about the launch, Andreas Dotterweich, Senior Vice President of Aurora Europe, emphasized that these new websites signify Aurora's ongoing dedication to growth in its fastest expanding region. He remarked on the importance of these platforms in showcasing Aurora's scientific knowledge, product offerings, and partnerships, ultimately serving as essential resources for healthcare practitioners.

Enhancing User Experience with Local Relevance

The refreshed websites not only display Aurora’s renowned manufacturing strength but also spotlight both Canadian-made and local products. They include updated visuals and videos, enhancing quality compliance information while promoting an evidence-based approach to their processes.

Users can expect a seamless browsing experience as the sites are designed to cater to the native languages of their respective markets. This thoughtful consideration mirrors Aurora's broader European communication strategy. By presenting a locally attuned information portal, Aurora aims to fortify its engagement with stakeholders while capturing new opportunities in the evolving medical cannabis landscape.

Showcasing Leadership and Quality

The new digital presence reinforces Aurora's position as a trusted leader in the medical cannabis space. They highlight the company's ongoing efforts to deliver consistent, high-quality cannabis products while showcasing its dedication to patient care and scientific advancement. Aurora’s initiative exemplifies how innovative digital strategies can shape a brand's image and outreach in a competitive market.

About Aurora Cannabis

Aurora Cannabis is recognized globally for its medical cannabis contributions, with an unwavering focus on improving lives through scientific research and patient-centric care. The company caters to both medical and consumer segments across regions, including Canada, Europe, Australia, and New Zealand. Aurora's product portfolio features trusted brands such as Aurora®, MedReleaf®, Pedanios®, among others. With advanced manufacturing facilities in Canada and Germany, coupled with a team of experts, Aurora continues to expand its international footprint and deliver high-quality cannabis solutions aimed at Opening the World to Cannabis™.

Conclusion

Aurora's strategic launch of its new European websites not only exemplifies its commitment to growth but positions the company as a key player in the future of medical cannabis in Europe. By continuously enhancing their digital infrastructure and local relevance, Aurora Cannabis remains poised to leverage their scientific expertise and market insights to drive both engagement and growth across the continent.